Work

A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer

Year: 2005

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-004-0996-6

Authors: Grace K. Dy, Sumithra Mandrekar, Prema P. Peethambaram, Scott H. Okuno, Gary C. Croghan, Lorelei J. Hanson, Alfred Furth, Alex A. Adjei

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2171087478

FWCI: 0.765

Cites: 30

Cited by: 7

Related to: 10